기본 콘텐츠로 건너뛰기

Discovery & Pre-Clinical/Clinical Development

Associate Director, Biomarker Strategy, Interventional Oncology (INTO)

  • 타이틀 Associate Director, Biomarker Strategy, Interventional Oncology (INTO)
  • 부서 Discovery & Pre-Clinical/Clinical Development
  • 하위 기능 Clinical Development & Research & Non-MD
  • 범주 Senior Principal Scientist, Clinical Development & Research - Non-MD (ST8)
  • 위치 Spring House, Pennsylvania, United States; Raritan, New Jersey, United States; New Brunswick, New Jersey, United States
  • 게시
  • 참조 2406184251W
지금 신청하기
공유

묘사

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/. 

Interventional Oncology (INTO) is recruiting for an Associate Director, Biomarker Strategy located in Spring House, PA or Raritan, NJ. Remote based candidates within North America may be considered on a case-by-case basis and if approved by the company.

Interventional Oncology is a cross-sector program within Johnson & Johnson Global External Innovation (GEI) to transform the treatment of oncology patients. The Associate Director, Biomarker Strategy will have responsibility for developing and effectively implementing biomarker strategies to support the clinical development plans for projects within the Interventional Oncology portfolio. Working as part of the development team, the candidate will develop and validate molecular, immunological, pathological, and/or imaging biomarkers to select patients, monitor pharmacodynamic activity and evaluate response to treatment.  Additionally working with the Discovery team to support the clinical translation of the Interventional Oncology preclinical portfolio. 

Key Responsibilities:

·        Develop and maintain translational and clinical biomarker strategies to support assets within the Interventional Oncology portfolio

·        Contribute biomarker strategy input at development team meetings and governance reviews

·        Support the development of biomarker related aspects of the trial design, study protocols, lab manuals, clinical study reports, investigator brochures and regulatory documents

·        Work with the Biomarker Operations team and biomarker vendors to deliver validated biomarker assays

·        Collaborate with the Discovery team to develop plans for clinical translation of biomarkers

·        Work with the Data Science group to develop and implement data analysis strategies to deliver biomarker plans

자격

Qualifications / Required Experience and Skills:

·        PhD in life sciences is required.

·        Six or more years of experience in biomarker development and implementation in oncology clinical trials is required.

·        Experience and track-record of the discovery, validation and clinical implementation of biomarker readouts-especially genomic and transcriptomic profiling, histological/pathological readouts, and immunological readouts is required.

·        Experience of working with Contract Research Organizations to deliver biomarker readouts is required.

·        Knowledge and track-record of working to GCP principles as part of a clinical study team is required.

·        Working knowledge of analytical approaches to biomarker datasets-particularly complex biomarker datasets e.g. genomics datasets (DNA-seq/RNA-seq etc) is required.

·        Ability to work on global cross-functional teams is required.

·        Ability to influence teams and key stakeholders is required. 

Preferred Experience and Skills:

·        Knowledge and experience of implementing biomarkers in lung and/or head and neck cancer clinical trials is preferred.

·        Experience with intra-tumoral therapies including oncolytic viruses an advantage is preferred.

·        Awareness and preferably experience of predictive biomarkers including diagnostic development is preferred. 

The anticipated base pay range for this position is $131,000 to $225,400. The Company maintains highly competitive, performance-based compensation programs. Under current guidelines, this position is eligible for an annual performance bonus in accordance with the terms of the applicable plan. The annual performance bonus is a cash bonus intended to provide an incentive to achieve annual targeted results by rewarding for individual and the corporation’s performance over a calendar/ performance year. Bonuses are awarded at the Company’s discretion on an individual basis. Employees may be eligible to participate in Company employee benefit programs such as health insurance, savings plan, pension plan, disability plan, vacation pay, sick time, holiday pay, and work, personal and family time off in accordance with the terms of the applicable plans. The compensation and benefits information set forth in this posting applies to candidates hired in the United States.  Candidates hired outside the United States will be eligible for compensation and benefits in accordance with their local market. For additional general information on company benefits, please go to: https://www.careers.jnj.com/employee-benefits

Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability.

For more information on how we support the whole health of our employees throughout their wellness, career and life journey, please visit www.careers.jnj.com.